Neuromeka Co., Ltd. (KOSDAQ:348340)
South Korea flag South Korea · Delayed Price · Currency is KRW
20,700
+1,270 (6.54%)
Aug 10, 2026, 3:30 PM KST

Neuromeka Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
18,77318,95425,26913,7439,7557,351
Revenue Growth
-24.31%-24.99%83.87%40.89%32.69%80.81%
Gross Profit
3,4003,3204,0611,1631,0831,797
Operating Income
-15,154-14,857-19,439-14,825-7,809-3,009
Net Income
-40,278-21,973-16,755-17,654-8,201-6,594
Earnings Per Share
-2323.17-1304.24-1059.32-1129.32-635.33-610.81
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
8,74918,22820,03540,95528,79015,891
Total Debt
35,85753,52455,59141,0772,3183,629
Net Cash (Debt)
-27,107-35,296-35,556-121.9326,47212,262
Net Cash Growth
----115.88%13304.69%
Net Cash Per Share
-1563.44-2095.05-2248.03-7.802050.881135.85

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-12,565-11,358-21,930-12,434-7,999-1,056
Capital Expenditures
-3,008-3,153-13,695-30,491-3,009-210.55
Free Cash Flow
-15,572-14,511-35,625-42,925-11,008-1,267
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
18.11%17.52%16.07%8.46%11.10%24.44%
Operating Margin
-80.72%-78.38%-76.93%-107.88%-80.06%-40.93%
Pretax Margin
-214.68%-115.67%-66.18%-128.40%-84.07%-89.70%
Profit Margin
-214.55%-115.93%-66.30%-128.46%-84.07%-89.70%
FCF Margin
-82.95%-76.56%-140.98%-312.34%-112.85%-17.23%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-107.87107.8760.70--
PS Ratio
19.2619.7612.0628.2413.19-